Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
This grant funds collaborative and innovative projects in clinical and translational science.
About this program
The Clinical and Translational Science Award (CTSA) Program aims to accelerate the translation of scientific discoveries into clinical applications. This specific grant, the Collaborative and Innovative Acceleration Award, supports projects that foster collaboration among researchers and institutions to enhance the efficiency and effectiveness of clinical trials. It is designed for institutions engaged in clinical and translational research, providing them with the necessary resources to innovate and improve health outcomes. Eligible applicants include academic institutions, research organizations, and other entities involved in clinical research. The program encourages innovative approaches that can lead to significant advancements in the field. By facilitating collaboration and providing funding, the CTSA program aims to bridge the gap between laboratory research and patient care, ultimately benefiting public health.
Eligibility
Academic institutions, research organizations, and other entities involved in clinical research.